Crispr News

• Interfering With Invasive Mussels | Genomeweb - GenomeWeb
  July 30, 2021
• CRISPR anticipates filing of lead candidate CTX001 in 18 to 24 months - Seeking Alpha
  July 30, 2021
• Vertex Hopes to Channel CF Drug Successes into Other Therapies in the Pipeline - BioSpace
  July 30, 2021
• In vivo gene editing alleviates amyloid pathologies - BioWorld Online
  July 30, 2021
• Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - PRNewswire
  July 30, 2021
• USU president chairs national task force seeking updates on federal regulations overseeing gene-edited animals - Cache Valley Daily
  July 30, 2021
• A sterile solution: How Crispr could protect wild salmon - Salon
  July 30, 2021
• Why CRISPR Therapeutics' Stock Is Trading Higher Today - Benzinga
  July 30, 2021
• Chardan Capital Stick to Their Buy Rating for Crispr Therapeutics AG By Investing.com - Investing.com
  July 30, 2021
• Crispr Therapeutics AG (CRSP) Up 5.00% in Premarket Trading - InvestorsObserver
  July 30, 2021
• CRISPR gene editing debuts in space, as astronauts study how DNA repairs itself from cosmic radiation - Genetic Literacy Project
  July 30, 2021
• CRISPR Therapeutics AG (CRSP) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
  July 29, 2021
• CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
  July 29, 2021
• Diving into the genome's uncharted territories - Axios
  July 29, 2021
• CRISPR Therapeutics Provides Business Update and Reports - GlobeNewswire
  July 29, 2021
• Listen: The quest for a Covid pill & a microbiome gut-check - STAT - STAT
  July 29, 2021
• Chancellor's Innovation Fund Catalyzes 6 Promising Projects - NC State News
  July 29, 2021
• Analyzing CRISPR Therapeutics's Unusual Options Activity - Benzinga
  July 29, 2021
• Battling Covid-19 with gene technology - New Straits Times
  July 29, 2021
• Accelerating Biopharmaceutical Development With Synthetic Biology - Technology Networks
  July 29, 2021